CLINICAL_TRIALS
trial_result
· 2013-05-14
Clinical Trial Update: Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy [Phase 4]
Summary
Phase 4 trial evaluating probenecid in epilepsy was terminated; results were posted on May 14, 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jim McAuley | Conditions: Epilepsy | Phase 4 | Status: TERMINATED | Results posted: 2013-05-14